| 730268 |
FRONTIERS IN ONCOLOGY |
The Role of the Metabolic Parameters of 18F-FDG PET/CT in Patients With Locally Advanced Cervical Cancer |
2021-08-19 |
10.3389/fonc.2021.698744 |
Wang Dunhuang, Liu Xiaoliang, Wang Weiping, Huo Li, Pan Qingqing, Ren Xue, Zhang Fuquan, Hu Ke |
| 730267 |
FRONTIERS IN ONCOLOGY |
Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses |
2021-08-19 |
10.3389/fonc.2021.731598 |
Scarpitta Allan, Hacker Ulrich T., Büning Hildegard, Boyer Olivier, Adriouch Sahil |
| 730266 |
FRONTIERS IN ONCOLOGY |
Combination of the Distance From Tumor Edge to Subventricular Zone and IDH Mutation Predicts Prognosis of Patients With Glioma |
2021-08-19 |
10.3389/fonc.2021.693693 |
Zhang Shuixian, Zhao Fengchun, Zhou Tengyuan, Liu Dan, Yao Xiaohong, Fu Wenjuan, Liu Zhi, Lan Chuan, Lai Zhaopan, Liu Chen, Li Haitao, Li Yuhong, Hu Shengli, Yin Yi, Tan Liang, Li Wenyan, Li Fei, Hu Rong, Feng Hua |
| 730265 |
FRONTIERS IN ONCOLOGY |
Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma |
2021-08-19 |
10.3389/fonc.2021.700700 |
Xu Weikang, Lu Xinyu, Liu Jing, Chen Qianhui, Huang Xuan, Huang Kuiyuan, Liu Hongyan, Zhu Wei, Zhang Xiaoyong |
| 730264 |
FRONTIERS IN ONCOLOGY |
TIMELESS Promotes Tumor Progression by Enhancing Macrophages Recruitment in Ovarian Cancer |
2021-08-19 |
10.3389/fonc.2021.732058 |
Xing Xin, Gu Fei, Hua Lanyu, Cui Xiaoxiao, Li Dongxue, Wu Zhiyong, Zhang Rong |
| 730263 |
FRONTIERS IN ONCOLOGY |
Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate Cancer |
2021-08-19 |
10.3389/fonc.2021.721659 |
Hamid Agus Rizal A. H., Luna-Velez Maria V., Dudek Aleksandra M., Jansen Cornelius F. J., Smit Frank, Aalders Tilly W., Verhaegh Gerald W., Schaafsma Ewout, Sedelaar John P. M., Schalken Jack A. |
| 730262 |
FRONTIERS IN ONCOLOGY |
Efficacy and Safety of Anti-HER2 Agents in Combination With Chemotherapy for Metastatic HER2-Positive Breast Cancer Patient: A Network Meta-Analysis |
2021-08-19 |
10.3389/fonc.2021.731210 |
Zhang Xiaohui, Leng Junsheng, Zhou Yidong, Mao Feng, Lin Yan, Shen Songjie, Sun Qiang |
| 730261 |
FRONTIERS IN ONCOLOGY |
Development and Validation of Prognostic Nomogram for Primary Peritoneal Serous Carcinoma Compared With FIGO Staging System: A Population-Based Study |
2021-08-19 |
10.3389/fonc.2021.651969 |
Chen Ming, Wen Zhenzhen, Qi Zhengwei, Gao Min |
| 730260 |
FRONTIERS IN ONCOLOGY |
Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis |
2021-08-19 |
10.3389/fonc.2021.657984 |
Hu Xiaoyun, Chen Qiuchen, Guo Hao, Li Kuo, Fu Boshi, Chen Yu, Zhao Haishan, Wei Minjie, Li Yalun, Wu Huizhe |
| 730259 |
FRONTIERS IN ONCOLOGY |
Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review |
2021-08-19 |
10.3389/fonc.2021.648187 |
Xin Lei, Gao Jinfang, Zheng Ziliang, Chen Yiyou, Lv Shuxin, Zhao Zhikai, Yu Chunhai, Yang Xiaotang, Zhang Ruiping |
